Jorine ‘t Lam-Boer
A5087397023- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Colorectal and Anal Carcinomas
- Colorectal Cancer Surgical Treatments
- Hepatocellular Carcinoma Treatment and Prognosis
- Genetic factors in colorectal cancer
- Multiple and Secondary Primary Cancers
- Health Systems, Economic Evaluations, Quality of Life
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Treatment and Pharmacology
- Cardiac, Anesthesia and Surgical Outcomes
- Colorectal Cancer Screening and Detection
- Lung Cancer Treatments and Mutations
- Pancreatic and Hepatic Oncology Research
- Cancer Diagnosis and Treatment
Radboud University Nijmegen
2015-2024
Radboud University Medical Center
2015-2024
The Netherlands Cancer Institute
2024
As the value of palliative primary tumor resection in stage IV colorectal cancer (CRC) is still under debate, purpose this population‐based study was to investigate if as initial treatment after diagnosis associated with improved overall survival. All patients adenocarcinoma (2008–2011) were selected from Netherlands Cancer Registry, and undergoing curative intent ( i.e ., metastasectomy, radiofrequency ablation and/or hyperthermic intraperitoneal chemotherapy), or best supportive care...
<h3>Importance</h3> The role of primary tumor resection (PTR) in synchronous patients with metastatic colorectal cancer (mCRC) who had unresectable metastases and few or absent symptoms their is unclear. Studying subgroups low postoperative mortality may identify potentially benefit from PTR. <h3>Objective</h3> To determine the difference 60-day between randomized to systemic treatment only vs PTR followed by treatment, explore risk factors associated mortality. <h3>Design, Setting,...
Upfront primary tumor resection (PTR) has been associated with longer overall survival (OS) in patients synchronous unresectable metastatic colorectal cancer (mCRC) retrospective analyses. The aim of the CAIRO4 study was to investigate whether addition upfront PTR systemic therapy resulted a benefit mCRC without severe symptoms their tumor.
<b><i>Introduction:</i></b> Neoadjuvant chemotherapy (CT) for locally advanced colon cancer (LACC) could potentially lead to tumor shrinkage, eradication of micrometastases, and prevention cell shedding during surgery. This retrospective study investigates the surgical oncological outcomes preoperative CT LACC. <b><i>Methods:</i></b> Using Netherlands Cancer Registry, data patients with stage II or III cancer, diagnosed between 2008 2016 was...
As the outcome of modern colorectal cancer (CRC) surgery has significantly improved over years, however, renewed and adequate risk stratification for mortality is important to identify high-risk patients. This population-based study was conducted analyse postoperative outcomes in patients with CRC create a model 30-day mortality.Data from Dutch Colorectal Audit were used assess differences (30-day mortality, hospital stay, blood transfusion, complications) treated 2009 2017. Time trends...